NMNorifumi Mizuno

Norifumi Mizuno

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Norifumi Mizuno has a total of 49 co-authors. Here are the top co-authors by number of shared publications:

  • Jiro Kawamori

    Department of Radiation Oncology, St. Luke's International Hospital, Tokyo, Japan

    6 shared publications
  • Tomoko Itazawa

    Department of Radiation Oncology, St. Luke’s International Hospital, Tokyo, JPN

    6 shared publications
  • Ryohei Yamauchi

    Department of Radiation Oncology, St. Luke's International Hospital, Tokyo, Japan

    5 shared publications
  • Masatsugu Hariu

    Department of Radiation Oncology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan

    3 shared publications
  • Ryouhei Yamauchi

    Department of Radiation Oncology, St. Luke’s International Hospital, Chuo-ku, Tokyo, Japan

    3 shared publications
  • Shogo Hatanaka

    Department of Radiation Oncology, St. Luke’s International Hospital, Chuo-ku, Tokyo, Japan

    3 shared publications

Latest Publications

  • Open Access

    Multi‐institutional study on the commissioning and clinical implementation of the TrueBeam enhanced leaf model in the Eclipse treatment planning system

    by Ryohei Miyasaka, Ryuta Hirai, Yuhi Suda, Ryohei Yamauchi, Norifumi Mizuno, Yuya Suzuki, Mitsunobu Igari, Tomohiro Ohta, Hiroki Nakayama, Yu Arai, et al.

    Purpose: Recently, the Enhanced Leaf Modeling (ELM) was developed to improve the multileaf collimator (MLC) model in the Eclipse treatment planning system (TPS). This multi‐institutional study evaluated the dose calculation accuracy and clinical feasibility of the ELM for TrueBeam linear accelerators (linacs) equipped with Millennium 120 and High‐Definition 120 MLCs. In addition, to facilitate broader clinical adoption, the feasibility of using machine‐averaged ELMs (ELM Ave ) for both MLC types was evaluated. Methods: Twelve TrueBeam linacs from nine institutions were included. Machine‐specific ELM (ELM MS ) parameters, including Leaf Transmission (LT) and the Leaf Gap (LG), were derived from vendor MLC sequences. Three volumetric modulated arc therapy (VMAT) plans for prostate cancer, head and neck cancer, and spinal metastasis were calculated using Acuros XB with each ELM MS and verified using an ionization chamber and either Delta4 or ArcCHECK systems, based on relative dose differences and gamma pass rates (3%/2 mm). Verification criteria were set as tolerance and action levels of ≤2% and ≤3% for relative dose difference and ≥95% and ≥90% for gamma pass rate. To further improve the ELM dose calculation accuracy for VMAT cases, the LT and LG parameters were systematically adjusted based on the verification results and then averaged across all linacs to obtain the ELM Ave, which was subsequently verified using the same procedure. Results: For the ELM MS dose calculations, the relative dose differences across the three VMAT cases averaged −1.13%, with a two‐standard deviation (2 SD) of 1.04%. The mean gamma pass rate for all dose profiles was 99.4% (2 SD = 2.6%). The ELM MS achieved clinically acceptable accuracy, with 96.3% of the verification results within clinical tolerance and no cases exceeding the action level. After parameter tuning, the ELM Ave calculations exhibited dose differences within ±2% and gamma pass rates above 96% across all verification cases investigated in this study. Conclusions: The ELM MS demonstrated reliable VMAT dose calculation accuracy across multiple institutions and MLC types. Tuning the LT and LG parameters can further improve ELM performance in various VMAT plans. The tuned ELM Ave satisfied all clinical tolerance criteria in all verification cases and may serve as a practical approach for efficient commissioning and objective evaluation of ELM parameters across institutions.


  • Open Access

    Dosimetric Comparison of 3D Conformal Radiotherapy (3D-CRT), Intensity-Modulated Radiotherapy (IMRT), and Volumetric-Modulated Arc Therapy (VMAT) in Cardiac-Sparing Whole Lung Irradiation

    by Ryohei Yamauchi, Shinobu Akiyama, Norifumi Mizuno, Takako Kobayashi, Tomoko Itazawa, Tomoyuki Masuda, Miki Hirano, Fumihiro Tomita, Yosuke Hosoya, Jiro Kawamori

    Introduction Whole lung irradiation (WLI) is used for the treatment of lung metastasis in Wilms tumor and Ewing sarcoma; however, cardiac complications are one of the concerns. We report the dosimetric advantages of WLI using volumetric-modulated arc therapy (VMAT) and present a dosimetric comparison of VMAT with anteroposterior-posteroanterior (AP-PA) and static-field intensity-modulated radiation therapy (IMRT). Additionally, we evaluated the dosimetric impact of respiratory motion and intra-fractional motion during VMAT treatment. Methods Seven patients were recruited in this study. AP-PA, IMRT, one-isocenter (1-IC) VMAT, and 2-IC VMAT were planned on the maximum inspiration and expiration CT, respectively. The prescribed dose was 15 Gy in 10 fractions. To determine the effects of respiratory motion, the CT series was replaced and the dose was evaluated while maintaining the beam information. To determine the effect of patient motion, perturbed dose calculations were performed using a two-IC VMAT. The perturbation doses were calculated by shifting only the IC of the one side beam by 3 mm or 5 mm in the right-to-left (RL) direction. Results The mean heart dose was 1467.0 cGy, 790.0 cGy, 764.2 cGy, and 738.4 cGy for AP-PA, IMRT, 1-IC VMAT, and 2-IC VMAT, respectively. When the expiration CT plan was recalculated with inspiration CT, Dmax increased approximately by 8%. In the 2-IC VMAT plan, the D50%, D98%, and D2% dose differences were within ±2%, even with a 5 mm IC shift. Conclusion We confirmed a significant dosimetric advantage of VMAT over other techniques. 2-IC VMAT should be considered an effective treatment option during irradiation for large target volumes.


  • Clinical evaluation of deep learning and atlas-based auto-segmentation for organs at risk delineation

    by Ryohei Yamauchi, Tomoko Itazawa, Takako Kobayashi, Shiho Kashiyama, Hiroyoshi Akimoto, Norifumi Mizuno, Jiro Kawamori


  • Establishing quality indicators to comprehensively assess quality assurance and patient safety in radiotherapy and their relationship with an institution’s background

    by Norifumi Mizuno, Hiroyuki Okamoto, Toshiyuki Minemura, Shinji Kawamura, Naoki Tohyama, Masahiko Kurooka, Ryu Kawamorita, Masaru Nakamura, Yoshinori Ito, Yoshiyuki Shioyama, et al.


  • Open Access

    Evaluation of robustness in hybrid intensity-modulated radiation therapy plans generated by commercial software for automated breast planning

    by Norifumi Mizuno, Ryouhei Yamauchi, Jiro Kawamori, Tomoko Itazawa, Munefumi Shimbo, Keiichiro Nishimura, Takafumi Yamano, Shogo Hatanaka, Masatsugu Hariu, Takeo Takahashi

    This study aimed to evaluate the robustness against geometric uncertainties in the hybrid intensity-modulated radiation therapy (IMRT) plans generated by commercially available software for automated breast planning (ABP). The ABP plans were compared with commonly used forward-planned field-in-field (FIF) technique plans. The planning computed tomography datasets of 20 patients who received left-sided breast-conserving surgery were used for both the ABP and FIF plans. Geometric uncertainties were simulated by shifting beam isocenters by 2, 3, 5, and 10 mm in the six directions: anterior/posterior, left/right, and superior/inferior. A total of 500 plans (20 patients and 25 scenarios, including the original plan) were created for each of the ABP and FIF plans. The homogeneity index of the target volume in the ABP plans was significantly better (p < 0.001) than the value in the FIF plans in the scenarios of shifting beam isocenters by 2, 3, and 5 mm. Mean heart dose and percentage volume of lungs receiving a dose more than 20 Gy were clinically acceptable in all scenarios. The hybrid IMRT plans generated by commercially available ABP software provided better robustness against geometric uncertainties than forward-planned FIF plans.


  • Evaluation of a new commercial automated planning software for tangential breast intensity-modulated radiation therapy

    by Norifumi Mizuno, Ryouhei Yamauchi, Jiro Kawamori, Tomoko Itazawa, Munefumi Shimbo, Keiichiro Nishimura, Takafumi Yamano, Shogo Hatanaka, Masatsugu Hariu, Takeo Takahashi

    Automated treatment planning may decrease the effort required in planning and promote increased routine clinical use of intensity-modulated radiation therapy (IMRT) for many breast cancer patients. The aim of this study was to evaluate a new commercial automated planning software for tangential breast IMRT by comparing it with clinical plans from whole-breast irradiation. We prospectively enrolled 150 patients with Stage 0–1 breast cancer who underwent breast-conserving surgery at our institution between September 2016 and August 2017. Total doses of 42.56 Gy in 16 fractions (n = 98) or 50 Gy in 25 fractions (n = 44) were used. All treatment plans were retrospectively re-planned using the automated breast planning (ABP) software. All automated plans generated clinically deliverable beam parameters with no patient body collision and no contralateral breast pass through. The mean homogeneity index of the automatically generated clinical target volume, percentage volume of lungs receiving dose more than 20 Gy, mean heart dose, and dose to the highest irradiated 2-cc volumes of the irradiated volume were 0.077 ± 0.019, 4.2% ± 1.2%, 142 ± 69 cGy, and 105.8% ± 1.7% (prescribed dose: 100%), respectively. The mean planning time was 4.8 ± 1.4 min. The ABP software demonstrated high clinical acceptability and treatment planning cost efficiency for tangential breast IMRT. The ABP software may be useful for delivering high-quality treatment to a majority of patients with early-stage breast cancer.


  • Open Access

    Determination of the appropriate physical density of internal metallic ports in temporary tissue expanders for the treatment planning of post-mastectomy radiation therapy

    by Norifumi Mizuno, Haruna Takahashi, Jiro Kawamori, Naoki Nakamura, Mami Ogita, Shogo Hatanaka, Ryouhei Yamauchi, Masatsugu Hariu, Kenji Sekiguchi

    Some patients undergoing breast reconstruction require post-mastectomy radiation therapy, but the metallic ports used in temporary tissue expanders attenuate the X-rays. In this study, we evaluated by the film method, the attenuation of 4 MV and 6 MV X-rays after passing through a metallic port, with the aim of identifying a useful method for determining the appropriate density to use in the radiation treatment planning system (RTPS), taking into account the distance between the metallic port and the targets. Radiochromic film was used to measure depth doses after the X-rays passed through the metallic port. The physical density allotted to the metal port portion was varied on the RTPS within the range 1–16 g/cm3, and the physical density values were calculated that best reproduced the depth–dose distribution extrapolated from the film method. When the metallic port was orientated perpendicularly, the attenuation of the X-rays peaked at ~7% at both 4 MV and 6 MV. In the parallel orientation, the X-rays were attenuated by up to ~40% at 4 MV and by up to ~30% at 6 MV. We estimated the optimum physical density to be 9.8 g/cm3, which yielded the best fit with the actual measurements. We demonstrated the most likely range for the target depth from the CT images of actual patients and, within this range, we identified the optimum physical density at which the measured and calculated values were most consistent with each other.